Skip to content

Advertisement

  • Research Article
  • Open Access

Treatable causes of fever among children under five years in a seasonal malaria transmission area in Burkina Faso

  • 1, 2, 3Email author,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 2,
  • 2 and
  • 3
Infectious Diseases of Poverty20187:60

https://doi.org/10.1186/s40249-018-0442-3

  • Received: 2 November 2017
  • Accepted: 17 May 2018
  • Published:

Abstract

Background

Fever remains a major public health problem. In Burkina Faso, more than half of febrile children are considered not to be infected by malaria. This study prospectively assessed probable (treatable) causes of fever in Burkinabe children.

Methods

A prospective study was conducted among febrile children (≥37.5 °C) under 5 years of age presenting at four health facilities and one referral hospital in rural Burkina Faso. From each participant, blood was collected for malaria microscopy and culture, urine for dipstick testing and culturing if tested positive for leucocytes and nitrite, stool for rotavirus/adenovirus testing, culture and parasitology, and a nasopharyngeal swab for culture.

Results

In total 684 febrile children were included in the study. Plasmodium falciparum malaria was found in 49.7% (340/684) of the participants and non-malaria infections in 49.1% (336/684) of children. The non-nalaria infections included gastro-intestinal infections (37.0%), common bacterial pathogens of nasopharynx (24.3%), bacterial bloodstream infections (6.0%) and urinary tract infections (1.8%). Nearly 45% (154/340) of the malaria infected children were co-infected with non-nalaria infections, but only 3.2% (11/340) of these co-infections could be considered as a possible alternative cause of fever. In contrast, in the malaria microscopy negative children 18.0% (62/344) of the infections could be the probable cause of the fever. Pathogens were not isolated from 23.7% (162/684) of the febrile cases.

Conclusions

Malaria remains the most common pathogen found in febrile children in Burkina Faso. However, a relative high number of febrile children had non-malaria infections. The correct diagnosis of these non-malaria fevers is a major concern, and there is an urgent need to develop more point-of-care diagnostic tests and capacities to identify and treat the causes of these fevers.

Keywords

  • Fever
  • Children
  • Infectious diseases
  • Malaria

Multilingual abstract

Please Additional file 1 for translation in the five official working languages of the United Nations.

Background

Febrile illnesses remain a major public health problem in Sub-Saharan Africa (SSA). Fever is the most common clinical symptom found in children under five years of age presenting at health facilities [1, 2]. Nowadays in many malaria endemic areas, including Burkina Faso, more than half of these febrile children are considered not to be infected with malaria, as the incidence of this disease is declining due to increased control efforts over the last decade [36]. This, combined with the guidelines of the World Health Organization (WHO) that recommend to confirm a malaria infection in febrile children through a diagnostic test before giving antimalarial treatment [7], prompts the need to search for an alternative cause of fever. This has created a diagnostic dilemma for health workers, by having a large group of patients with so called “unexplained” or “non-malaria” fever and with few or no diagnostic tools available to guide the subsequence management of these febrile cases [810]. An alternative cause of fever may also be present in malaria positive children. Subsequently, lack of knowledge on the prevalence of other possible aetiologies of fever, limited access to proper diagnostic tests, as well as the fear of overlooking a potentially life threatening malaria infection are the main reasons why most febrile children still receive antimalarial treatment [1113].

The various possible aetiologies of a febrile illness are difficult to distinguish when only information from medical history and physical examination are available [14, 15]. Laboratory facilities are often scarce in health facilities in low-and middle-income countries [11, 16, 17]. Therefore, fever is routinely treated in these countries using only clinical signs and symptoms (empiric treatment) [18, 19]. Data are becoming available on the aetiologies of fever episodes in children under 5 years of age in SSA [2024]. It is noted that, next to malaria, viral infections are a very common cause of febrile disease [13, 21, 23], which cannot be treated with antibiotics. However, a significant number of febrile cases remain that do need treatment with appropriate antibiotics, but these treatable infections are often overlooked [20, 22]. The clinician needs to know the possible presence of other treatable infections amongst malaria-infected and uninfected children presenting with fever.

The present prospective study was designed and conducted to identify the pathogens that could cause fever in children seeking care at five health centres in rural Burkina Faso. Febrile patients were evaluated for a wide range of infections, with a focus on treatable bacterial and parasitic infections, using conventional diagnostic. This study contributes to a better understanding of possible causes of fever in children under 5 years of age living in a malaria endemic region.

Methods

Study site

This study was conducted in the rural district of Nanoro, Burkina Faso. Four peripheral health facilities (Urbain, Godo, Nazoanga and Seguedin) and the referral hospital Centre Medical Saint Camille of Nanoro were involved in the data and clinical specimen collection. The choice of the peripheral health facilities was based on their accessibility for patients and their distance to the research laboratory (maximum of 20 km). The district hospital was included as recruitment centre in order to be able to capture also the more severely ill children who were referred from peripheral health facilities.

Malaria transmission in Nanoro district is hyper endemic and occurs principally between July and November. In 2010, the average under five mortality rate in Burkina Faso was 129/1000 life-births [25]. Vaccination against Haemophilus influenzae type b was introduced into the extended program of immunization (EPI) in January 2006 (estimated coverage 86.8% in 2012 [26]) and against pneumococcal and rotavirus in October 2013 (Source: Ministry of Health, Burkina Faso).

Study design

A prospective study was conducted from January–December 2015. The study was approved by the National Ethical Committee in Health Research, Burkina Faso (Deliberation N°2014–11-130). All children under 5 years of age with an axillary temperature ≥ 37.5 °C presenting at one of the participating health facilities or the referral hospital were asked to participate in the study. Written informed consent was obtained from parent or legal guardian prior to enrolment. The medical history and findings from clinical examination of the child were recorded on a standard Case Report Form (CRF) by trained study nurses. The following clinical specimens were collected from each participant: blood, urine, stool and a nasopharyngeal swab. Parents or adult guardians were asked to complete sample collection within 48 h following inclusion when diagnostic specimen collection (stool and/or urine) could not be realized during the enrolment procedure. They were provided with instructions and sterile containers for that purpose. The parents or guardians were told to return the samples immediately after collection.

The participants were managed according to the national guidelines. If culture results or other laboratory tests justified additional or alternative treatment, the results were forwarded to the health facility. The parents or guardians were contacted as soon as possible to arrange that the necessary treatment would be given to the participant.

Laboratory procedures

Nasopharyngeal swab and blood samples were also collected in Skim Milk-Tryptone-Glucose-Glycerol (STGG) and Ethylene Diamine Tetra-Acetic Acid (EDTA) tube respectively. All samples were transported to the central microbiology laboratory of the Clinical Research Unit of Nanoro (CRUN) where the various laboratory tests were conducted.

Malaria testing

Giemsa stained thick and thin blood smears were prepared and independently read by two experienced microscopists. In case of discordance (i.e. positive vs. negative, difference in Plasmodium species, difference in parasite density > Log10 or ratio > 2 in case of parasite density ≤ 400/μl or > 400/μl) the respective slide was read by a third independent reader to make a final decision. The final parasite counts were the geometric means of the two reader’s results or the geometric means of the two geometrically closest reading in case of third reading. These results were expressed as asexual parasites per microliter by using the patient’s white blood cell (WBC) count.

Full blood counts

Blood samples were collected in EDTA tubes for full blood counts using a Sysmex XS1000i (Sysmex Corporation, Kobe, Japan) according to manufacturer’s instructions.

Blood culture

From each child, 1–3 ml of venous blood was directly collected in a paediatric blood culture bottle (BD BACTEC Peds Plus™/F, Becton Dickinson and Company, Sparks, Maryland, USA) and incubated in a BACTEC 9050 instrument (Becton Dickinson) for a total of 5 days. If flagged for bacterial growth, the cultures were subsequently Gram stained, sub-cultured on Eosin-Methylene Blue (EMB) agar, 5% Sheep Blood agar (bioMérieux, Marcy-l’Etoile, France) and chocolate + isovitalex agar, and incubated at 35–37 °C for 24 h. Isolates were identified by standard microbiological methods.

Stool examination

Fresh stool smears were prepared in normal saline and examined by direct microscopy for the presence of intestinal parasites. Parasite elements looked for were: cysts, eggs, and vegetative forms of protozoa. Furthermore, stools were plated on EMB, Hektoen agar and inoculated in selenite of sodium broth and incubated at 35–37 °C. After 4 h of incubation, selenite of sodium broth was sub-cultured on Salmonella and Shigella agar (SS agar). To assess the prevalence of rotavirus and adenovirus after the introduction of vaccine against rotavirus in 2013, stool samples were also analysed for group A rotavirus using one step rotavirus and adenovirus serotype 40/41 in human faeces (SD Bioline Rota/Adeno; Standard Diagnostics Inc., Korea).

Urine examination

Dipstick testing (UroColor, Standard Diagnostics Inc., Korea) was done for each urine sample and the parameters collected were: presence or not of blood, protein, leucocytes and nitrite in the sample. A culture of the sample was done in case testing for leucocytes and nitrate was positive. Urine was plated on Cystine Lactose Electrolyte Deficient and EMB agar when dipstick testing for leucocytes and nitrite was positive. The cultures were incubated at 35–37 °C for 24 h. Only samples that yielded pure bacterial growth of more than 105 colonies forming units (CFU)/ml were considered significant bacteriuria.

Nasopharyngeal specimen culture

A flexible flocked swab was introduced into the nasal passage and two rotations of swabbing were done. The swab was placed into STGG broth for storage and transportation. For analysis, nasopharyngeal swab was vortexed and 200 μl of this broth was inoculated in 10 ml of Todd-Hewitt (TH) broth for enrichment and incubated at 35–37 °C during 18 to 24 h. The TH broth was subsequently plated out and incubated at 35–37 °C for 24 h on sheep blood agar and chocolate + isovitalex agar and chapman (mannitol-salt) agar to detect Streptococcus and/or Staphylococcus species, respectively.

Interpretation of laboratory findings

For the purpose of this study, the infections found, except malaria, were considered to be non-malaria infections. The non-malaria infections were further classified as either “probable causes of fever” or “non-probable causes of fever”. The infections that could be considered as a “probable cause of fever” in the recruited cases were subsequently further regrouped in: bacterial bloodstream infections (bBSI), viral gastro-intestinal (vGII) caused by rotavirus or adenovirus, and urinary tract infections (UTI) [2730]. The infections that could be considered as “non-probable cause of fever” in the study cases, were regrouped in: bacterial gastro-intestinal infection (bGII), common bacterial pathogens of the nasopharynx (CBPN) and parasitic gastro-intestinal infection (pGII), except for amoeba.

Data analysis

Data management involved double data entry using Open Clinica software. Data analysis was done by using R software version 3.3.1 (R development core team 2016, R Foundation for Statistical Computing, Vienna, Austria). Categorical variables were summarized as proportions and Pearson’s Chi-square test or Fisher’s exact test were performed. Continuous variables were described by mean or median and compared by using the Student’s t-test. Binomial logistic regression was used to compare the relation between the presence of infection and demographic, clinical and laboratory data. The P value < 0.05 was considered as significant.

Results

Characteristic of the study population

A total of 1447 children under 5 years of age, attending one of the participating health facilities or the referral hospital during the year 2015, were screened. 796 (55.0%) children were febrile (axillary temperature ≥37.5 °C) and 684 febrile children (85.9%) were included in the study. The study flow chart is presented in Fig. 1. Reasons for exclusion were: residence outside the health facilities catchment areas or failing to obtain consent from parents or guardians. The mean age of the recruited children was 22.4 months (Standard deviation [SD] = 14.1) and 29.4% were under 12 months of age. Mean axillary body temperature was 38.7 °C (37.5–41.0 °C) (Table 1).
Fig. 1
Fig. 1

Study flow chart

Table 1

Demographic characteristics, clinical symptoms and basic laboratory findings of study subjects enrolled in the present study in four rural health centres and one referral hospital in Nanoro Health district

Category

Subcategory

N

Proportion (%)

Gender

Male

369

53.95

Female

315

46.05

Age

≤12 months

201

29.39

>12 months

483

70.61

Temperature

≥37.5 °C–≤38.5 °C

340

49.71

>38.5 °C–≤39.5 °C

242

35.38

>39.5 °C

102

14.91

Duration of fever

1 day

108

15.79

2–3 days

518

75.73

4–7 days

56

8.19

>7 days

2

0.29

Vaccination according to the EPI

Yes

449

65.64

No

133

19.44

Unknown

102

14.91

Common symptoms

Cough

335

48.98

Diarrhoea

266

38.89

Vomiting

123

17.98

Others

55

8.04

Basic laboratory findings

Haemoglobin rate

  

< 8 g/dl

180

26.32

≥ 8 g/dl–<11 g/dl

418

61.11

≥11 g/dl

86

12.57

White blood cells

  

<4 × 103 cells/mm3

10

1.46

≥4 ×103 cells/mm3–< 12 × 103 cells/mm3

348

50.88

≥12 × 103 cells/mm3

326

47.66

EPI Expanded program of immunization

Clinical specimens for blood culture and malaria microscopy were obtained from all study cases. The proportion of stool and urine samples collected was 76.5% (523/684) and 74.1% (507/684), respectively. A small proportion (61/684, 8.9%) of nasopharynx cultures could not be performed, because the training of study nurses to collect nasopharyngeal swabs was completed after the start of inclusion (Fig. 1 and Table 2).
Table 2

Microbiology and malaria microscopy findings of children under-5 years enrolled in the study

Subcategory

General population

n/N (%)

Referral hospital

n/N (%)

Health facilities

n/N (%)

Malaria microscopy

684/684 (100)

138/138 (100)

546/546 (100)

 Malaria microscopy positive

340/684 (49.71)

41/138 (29.71)

299/546 (54.76)

  Plasmodium falciparuma

340/340 (100)

41/138 (29.71)

299/546 (54.76)

  Plasmodium malariae

04/340 (0.88)

0/138 (0)

4/299 (1.34)

  Plasmodium ovalae

01/340 (0.29)

0/138 (0)

1/299 (0.33)

Blood cultures (N = 684)

684/684 (100)

138/138 (100)

546/546 (100)

 Bacterial culture positive

41/684 (5.99)

21/138 (15.22)

20/546 (3.66)

  Non-Typhoid Salmonella spp.

31/41 (75.61)

19/21 (90.48)

12/20 (60.00)

  Salmonella typhi

02/41 (4.88)

00

02/20 (10.00)

  Escherichia coli

01/41 (2.44)

00

01/20 (5.00)

  Staphylococcus aureus

02/41 (4.88)

01/21 (4.76)

01/20 (5.00)

  Streptococcus pneumoniae

03/41 (7.31)

01/21 (4.76)

02/20 (10.00)

  Neisseria meningitidis

02/41 (4.88)

00

02/20 (10.00)

Urine examination (N = 507)

507/684 (74.12)

94/138 (68.12)

413/546 (75.64)

 Bacterial culture positive

10/507 (1.97)

04/94 (4.26)

06/413 (1.45)

  Escherichia coli

10/10 (100.00)

04/4 (100)

06/6 (100)

Stool examinations (N = 523)

523/684 (76.46)

85/138 (61.60)

438/546 (80.22)

 Bacterial culture positive

40/523 (7.65)

09/85 (10.59)

31/438 (7.08)

  Non-Typhoid Salmonella

20/40 (50.00)

08/9 (88.89)

16/31 (38.71)

  Escherichia coli

17/40 (42.50)

01/9 (11.11)

16/31 ()51.61

  Shigella

03/40 (7.50)

00

03/31 (9.69)

 Parasites positive

143/523 (27.34)

17/85 (20.00)

126/438 (28.77)

  Mono parasitosisb

115/143 (80.42)

11/17 (64.71)

104/126 (82.54)

  Bi parasitosis

25/143 (17.48)

05/17 (29.41)

20/126 (15.87)

  Tri parasitosis

03/143 (2.10)

01/17 (5.88)

02/126 (1.59)

 Rotavirus/Adenovirus positive

25/523 (4.78)

04/85 (4.71)

21/438 (4.80)

  Rotavirus

15/25 (60.00)

00

15/21 (71.43)

  Adenovirus

10/25 (40.00)

04/4 (100)

06/21 (28.57)

Nasopharyngeal cultures (N = 629)

629/684 (91.95)

137/138 (99.28)

492/546 (90.11)

 Bacterial culture positive

153/629 (24.32)

41/137 (29.71)

112/492 (22.77)

  Staphylococcus aureus

148/153 (96.73)

41/41 (100)

107/112 (95.54)

  Streptococcus pneumoniae

05/153 (3.27)

00

05/112 (4.46)

No pathogens detected

162/684 (23.68)

40/138 (28.99)

122/546 (22.34)

a: 5 children infection with Plasmodium falciparum were co-infected with P. malariae and P. ovale

b: Giardia intestinalis: 35.65%; Trichomonas intestinalis: 22.61%; Endolimax nana: 17.40%; Entamoeba coli: 13.91%; Entamoeba hystolitica: 7.82%; Others: 2.61%

Prevalence of malaria and other pathogens in the febrile study cases

Malaria (confirmed by positive microscopy) was found in 49.7% (340/684) of the cases. Malaria occurred whole year round (Fig. 2). All 340 malaria microscopy positive cases were infected with Plasmodium falciparum, but five children were co-infected with other Plasmodium-species (i.e. 4 with P. malariae and 1 with P. ovale). The geometric mean parasite density was 24 003 parasites/μl (range: 72–2 272 500). Malaria was more prevalent in children presenting at the health facilities than at the referral hospital (Table 2).
Fig. 2
Fig. 2

Distribution of pathogens found with microbiology during the whole study (year 2015). BSI Bloodstream infection (bacterial), GII Gastro-intestinal infection (all), UTI Urinary tract infection, CBPN common bacterial pathogens of nasopharynx

Bacteria could be identified in 6.0% (41/684) of blood cultures, 2.0% (10/507) urine cultures, 7.7% (40/523) stools and 24.3% (154/623) nasopharyngeal cultures. Parasites were found in 27.3% (143/523) of the collected stool specimen and 4.8% (25/523) of these samples were positive for rotavirus/adenovirus. Pathogens could not be detected in 162 children (23.7% of the study population) (Table 2).

A pathogen (other than malaria) was identified in 10.7% (73/684) of the febrile children that could be “a probable cause of fever” (Table 2). Of these pathogens, 6.0% (41/684) was a bacterial bloodstream infection (bBSI), 4.8% (25/253) was a viral gastro-intestinal tract infection (vGII) and 2% (10/507) was a urinary tract infection (UTI). Only mono-infections were found in the bacterial cultures (bBSI and UTI). Non-typhoid Salmonella was the dominant bacterium isolated from positive blood cultures (75.6%, 31/41) and all ten positive urine cultures contained Escherichia coli (10/10). Rotavirus was the main virus detected in positive stools tested with rotavirus/adenovirus tests (60%, 15/25). Pathogens that could be “a probable cause of fever” (bBSI and UTI, except for vGII) were more often found in clinical specimen from children presenting at the referral hospital than in those presenting at the peripheral health facilities (Table 2).

In 40.8% (279/684, i.e. 143 children in the malaria microscopy positive group and 136 children in the malaria microscopy negative group) of the febrile children one or more pathogens were identified that could be considered as “non-probable cause of fever” (Table 3). Parasites were detected in 27.3% (143/523) of the stool samples. Giardia intestinalis was the most frequently found parasite in stool samples 46.2% (66/143). Pathogenic bacteria were isolated from 7.7% (40/523) of the stool samples (Table 2). The most often isolated bacterial species from stool was non-typhoid Salmonella 50.0% (20/40). Nasopharyngeal swab cultures were positive for 24.3% (153/629) of the febrile cases. Staphylococcus aureus was the most frequently found species 96.7% (148/153) amongst the common bacterial pathogens of nasopharynx (CBPN). The prevalence of pathogens that were probably not the cause of fever was more or less similar in clinical specimen from children presenting at the referral hospital and in those presenting at the peripheral health facilities (see Table 2).
Table 3

Interaction between malaria and others pathogens studied

 

Malaria microscopy positive (340)

n (%)

Malaria microscopy negative (344)

n (%)

Other infections

154 (45.29)

182 (52.91)

Probable cause of fever (BSI, vGII, UTI)

11 (3.23)

62 (18.02)

No probable causes of fever (pGII, bGII, CBPN)

143 (42.05)

136 (39.53)

bBSI

6 (1.76)

35 (10.17)

GII (all)

90 (26.47)

103 (29.94)

pGII

77 (22.64)

66 (19.18)

bGII

17 (5.0)

23 (6.69)

vGII

3 (0.88)

22 (6.40)

CBPN

75 (22.05)

78 (22.67)

UTI

3 (0.88)

7 (2.03)

bBSI bacterial bloodstream infection, GII Gastro-intestinal infection, pGII parasitic gastro-intestinal infection, bGII bacterial gastro-intestinal infection, vGII viral gastro-intestinal infection, UTI Urinary tract infection, CBPN Common bacterial pathogens of nasopharynx

All pathogens were found the whole year round except for UTI. Malaria followed more or less the typical seasonal distribution for the study area, with peak transmission between August and January (Fig. 2). CBPN were not studied during the first 2 months of the study. UTIs were found mainly during the second half of the year (Fig. 2).

Interaction between malaria and other pathogens

Additional pathogens, next to Plasmodium, were isolated from 45.3% (154/340) of the clinical samples obtained from children who were malaria microscopy positive (Table 3). Only 11/154 (7.1%) of these other pathogens were identified as a pathogen that could also be considered as a “probable cause of fever”. Consequently, 3.2% (11/340) of the malaria microscopy positive children were co-infected with other pathogens that could be a “probable cause of fever”. In the malaria microscopy negative group 52.9% (182/344) of other infections were found. A significant higher number of these pathogens, 18.0% (62/344), was identified as a “probable cause of fever” in the malaria negative group of children compared to the malaria infected cases (P < 0.001).

Correlation between the presence of infection and demographic, clinical and laboratory data

The correlation between the presence of an infection investigated in this study and the patient’s demographic, clinical and laboratory data is summarized in Table 4. The analysis showed a strong correlation between having a malaria infection and age > 12 months (OR = 2.85, 95% CI: 2.0–4.1, P < 0.001) or temperature > 39.5 °C (OR = 2.06, 95% CI: 1.3–3.3, P = 0.002). Furthermore, malaria was associated with white blood cell count > 12 × 103 cells/mm3, and haemoglobin concentration < 11 g/dl (see Table 4).
Table 4

Correlation between malaria, BSI, UTI, GII and CBPN and demographic, clinical and laboratory data

 

Malaria

Blood stream infection

Urinary tract infection

Gastro-intestinal infection

CBPN

 

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

Gender

          

 Male

1

 

1

 

1

 

1

 

1

 

 Female

1.19 (0.88–1.61)

0.255

1.01 (0.53–1.91)

0.969

1.22 (0.34–4.45)

0.752

1.18 (0.83–1.69)

0.350

1.18 (0.82–1.70)

0.381

Age

          

 ≤12 months

1

 

1

 

1

 

1

 

1

 

 >12 months

2.85 (2.02–4.06)

<0.001*

0.70 (0.37–1.39)

0.299

0.34 (0.09–1.25)

0.094

2.88 (1.86–4.58)

<0.001*

0.90 (0.61–1.35)

0.609

Temperature

          

 37.5 °C–38.5 °C

1

 

1

 

1

 

1

 

1

 

 38.5 °C–39.5 °C

1.26 (0.91–1.76)

0.166

1.28 (0.64–2.51)

0.479

1.93 (0.50–7.92)

0.330

0.99 (0.67–1.47)

0.963

1.21 (0.81–1.80)

0.334

 >39.5 °C

2.06 (1.31–3.26)

0.002*

0.87 (0.28–2.23)

0.789

0.86 (0.04–5.90)

0.891

1.13 (0.67–1.89)

0.647

0.90 (0.50–1.55)

0.714

White cell counts

          

 4 × 103–12 × 103

1

 

1

 

1

 

1

 

1

 

 <4 × 103 cells/mm3

1.18 (0.33–4.67)

0.803

0.35 (0.02–7.31)

0.828

0.66 (0.20–26.68)

0.828

1.55 (0.36–6.70)

0.540

1.13 (0.01–2.31)

0.166

 ≥12 × 103 mm3

0.58 (0.43–0.79)

<0.001*

1.03 (0.55–1.91)

0.206

2.25 (0.64–7.92)

0.206

0.79 (0.55–1.14)

0.211

1.36 (0.94–1.95)

0.100

Anaemia

          

 ≥11 g/dl

1

 

1

 

1

1

1

 

1

 

 <8 g/dl

4.06 (2.35–7.20)

<0.001*

1.60 (0.54–5.80)

0.426

1.50 (0.31–10.70)

0.631

1.71 (0.39–1.28)

0.252

1.16 (0.64–1.18)

0.625

 8 g/dl–11 g/dl

2.51 (1.53–4.24)

<0.001*

1.25 (0.47–4.33)

0.688

0.34 (0.06–2.65)

0.248

0.60 (0.35–1.01)

0.052

0.81 (0.46–1.44)

0.453

Vaccination according EPI

          

 Yes

1

 

1

 

1

 

1

 

1

 

 No

0.78 (0.52–1.14)

0.204

0.68 (0.25–1.58)

0.409

0.12 (0.01–2.05)

0.145

1.23 (0.81–1.98)

0.294

0.98 (0.60–1.58)

0.950

 Unknown

1.32 (0.86–2.05)

0.204

0.90 (0.33–2.10)

0.829

0.16 (0.01–2.66)

0.201

1.11 (0.64–1.88)

0.709

1.06 (0.63–1.73)

0.829

*P-value is statistically significant

BSI Blood stream infection, UTI Urinary tract infection, GII Gastro - intestinal infection, CBPN Common bacterial pathogens of nasopharynx

Only age > 12 months was significantly associated with GII (OR = 2.9, 95% CI: 1.9–4.6, P < 0.001). Acorrelation between UTI or CBPN and the risk factors studied was not found.

Discussion

This study demonstrated that P. falciparum causing malaria is still the main pathogen identified in febrile children in the Nanoro region in Burkina Faso. As malaria can be relatively easily diagnosed, under-or overtreatment of this disease could be avoided if health workers adhere to the results of diagnostic testing [6, 31]. Next to malaria, a very small proportion of the febrile malaria-positive children were also co-infected with another potentially fever causing pathogen, such as a bacterial bloodstream infection (bBSI), which can cause a prolonged fever after successful malaria treatment. More importantly, if malaria is ruled out as the attributable cause of fever, the alternative cause fever should be established taking into account that in about 20% of the febrile malaria-negative children the actual cause of fever could either be a bBSI or a viral gastro-intestinal infection (vGII) or a urinary tract infection (UTI).

The prevalence and distribution of possible causes of fever found in the present study are in line with other studies performed in Sub-Sahara Africa in the same age group [29, 3237]. Importantly, the study re-emphasizes that a proper diagnosis of the cause of the fever episode in children in this age group followed by appropriate treatment is needed, as it will obviously save lives and prevent incorrect prescription of drugs. Only malaria can easily be diagnosed as a possible cause of fever in most health facilities in low and middle income countries at present. Therefore, there is a pressing need to develop practical tools (point-of-care or near point-of-care) to diagnose other treatable causes of fever in order to reduce morbidity and mortality in this age group [6].

Non-malaria infections that probably contributed to fever in this study were bBSI, UTI and vGII. The prevalence of bBSI was, despite differences in study designs, comparable to those reported in other studies in SSA (4 to 10%) [32, 3840]. The severely ill cases were referred to the referral hospital Centre Medical Saint Camille. This explains why bBSI and UTI cases were more prevalent in the referral hospital than in the rural health facilities. The high prevalence of Gram negative bacteria in general, and non-typhoid Salmonella in particular, is in agreement with a previous study in the same area, and with the global trend [41]. UTI found in this study was less prevalent than reported in studies from Tanzania and Nigeria. However, the predominant bacteria causing UTI in Nigeria and Tanzania were E. coli (as in this study) [22, 28, 4244]. In general, the hygienic conditions and sanitation are relatively good in the present study area and children are often well supervised by their parents or guardian, which could explain the low prevalence of UTI observed in this study. Around 5% of the febrile children were infected by vGII caused by rotavirus and adenovirus. This proportion is lower than that previously reported (33.8%) in Ouagadougou before the introduction of the rotavirus vaccine in Burkina Faso in 2013 [36]. The low prevalence observed in the current study could therefore be attributed to the rotavirus vaccination program in place in Burkina Faso. Contamination of stool cultures was not reported. However, 6.3% (32/507) of the urine samples collected by parents or guardians were contaminated. Urine collection is a rather difficult process, in particular to avoid contamination, and parents/guardians were not trained to do this and this explains the relative high rate of urine contaminations. Only 0.4% (3/684) of the blood samples collected by the nurses were contaminated.

This study also identified the presence of pathogens that can be considered as “non-probable cause of fever”, such as gastro-intestinal parasites, common bacterial pathogens of the nasopharynx and bacteria in stool. Still these pathogens require attention in patient management as they may affect health, for example in case the protective mucosal barrier of the intestine or nasopharynx is broken and they enter the blood stream [30, 45]. A limitation of the study is that viral respiratory tract infections, which are known to be a cause of fever [13, 2123, 4648] were not studied. These viral infections of the respiratory tract do not necessarily need treatment, and their detection require sophisticated laboratory facilities. As other studies have demonstrated that respiratory tract viral infections can be a major attributor to fever [2123], it might be possible that these pathogens are the cause of febrile illness in the children in which no probable causes of fever could be identified. The study revealed some correlations between the presence of an infection investigated and the patient’s demographic, clinical and laboratory data. In particular a relation between having malaria and moderate to severe anaemia was found, which is in line with previous findings in Nigeria and Ghana [49, 50]. Furthermore, children with a normal WBC had a higher risk of being infected with malaria than those having a high WBC [51]. A high temperature or high WBC counts was not predictive for a bacterial infection in the present study, which is in contrast to previous findings [39]. Significant other correlations were not found.

Conclusions

This study showed that malaria remains strongly associated with paediatric fever episodes in Nanoro. A relatively high number of non-malaria infections was found in malaria microscopy positive as well as malaria microscopy negative febrile children. Among these non-malaria infections, a “probable cause of fever” was mainly found in the malaria-negative febrile children. As treatment of several of these non-malaria infections is possible, there is a need for a practical tool to help clinician to screen for treatable causes of the febrile episodes. In the absence of such a diagnostic tool, malaria diagnostic test can be of help for the clinician to decide who should receive additional treatment, but over-or under-treatment will remain likely and puts febrile children at significant risk of morbidity and mortality.

Abbreviations

bBSI: 

bacterial bloodstream infection

bGII: 

bacterial gastro-intestinal infection

CBPN: 

Common bacteria pathogen of nasopharynx

CFU: 

Colonies forming units

CRF: 

Case report form

CRUN: 

Clinical research unit of Nanoro

EDTA: 

Ethylene diamine tetra acetic acid

EMB: 

Eosin methylene blue

EPI: 

Extended program of immunization

Log: 

Logarithm

pGII: 

parasitic gastro-intestinal infection

SD

Standard deviation

SS

Salmonella and Shigella

SSA: 

Sub-Saharan Africa

STGG: 

Skim milk-tryptone-glucose-glycerol

TH: 

Todd-hewitt

UTI: 

Urinary tract infection

vGII: 

viral gastro-intestinal infection

WBC: 

White blood cells

WHO: 

World Health Organization

Declarations

Acknowledgements

We thank the children and their parents or guardians for their participation in this study. We also acknowledge the staff of the Clinical Research Unit of Nanoro (Burkina Faso) for providing technical support during data and sample collection, transport and laboratory analysis. We extend our thanks to the staff of the four health facilities included in this study and the referral hospital Centre Medical Saint Camille of Nanoro.

Funding

This study was financially supported by The Netherlands Organization for Health Research and Development (ZonMw, project no. 205300005; RAPDIF: a rapid diagnostic test for undifferentiated fevers). The funder had not influence on the design of the study and the interpretation of the results.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

FK, HS, PM, HT and MBvH conceived and designed the study. FK, AS and MT supervised patient inclusion, taking of informed consent and diagnostic specimen collection by study nurses. KF, PL and MT performed the laboratory analyses. FK and TR analysed the data. FK, HS and MBvH drafted the manuscript and all authors commented on draft versions. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The study protocol was reviewed and approved by the National Ethical Committee in Health Research, Burkina Faso (Deliberation N°2014–11-130). Written informed consent was obtained from parents or guardians for the participation of the children prior to enrolment in the study.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Institut de Recherche en Science de la Sante-Unite de Recherche Clinique de Nanoro, Nanoro, Burkina Faso
(2)
Academic Medical Centre, Department of Medical Microbiology, Parasitology Unit, Amsterdam, The Netherlands
(3)
Global Child Health Group, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

References

  1. Nnedu ON, Rimel B, Terry C, Jalloh-Vos H, Baryon B, Bausch DG. Syndromic diagnosis of malaria in rural Sierra Leone and proposed additions to the national integrated management of childhood illness guidelines for fever. Am J Trop Med Hyg. 2010;82:525–8.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Richardson M, Lakhanpaul M, Guideline Development Group and the Technical Team. Assessment and initial management of feverish illness in children younger than 5 years: summary of NICE guidance. BMJ. 2007;334(7604):1163–4.Google Scholar
  3. Gething PW, Kirui VC, Alegana VA, Okiro EA, Noor AM, Snow RW. Estimating the number of paediatric fevers associated with malaria infection presenting to Africa’s public health sector in 2007. PLoS Med. 2010;7(7):e1000301.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Osei-Kwakye K, Asante KP, Mahama E, Apanga S, Owusu R, Kwara E, et al. The benefits or otherwise of managing malaria cases with or without laboratory diagnosis: the experience in a district hospital in Ghana. PLoS One. 2013;8(3):e58107.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Ouédraogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, Ouedraogo E, et al. Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso. PLoS One. 2013;8(1):e50036.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Kiemde F, Bonko M dit A, Tahita MC, Lompo P, Rouamba T, Tinto H, et al. Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission. Malar J. 2017;16(1):294.View ArticlePubMedPubMed CentralGoogle Scholar
  7. WHO. Guidelines for the treatment of malaria, 2nd edition. Who; 2010. 197p. http://apps.who.int/medicinedocs/documents/s19105en/s19105en.pdf.
  8. World Health Organization. World Malaria Report 2013. WHO; 2013. http://www.who.int/malaria/publications/world_malaria_report_2013/report/en/.
  9. O’Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10:545–55.View ArticlePubMedGoogle Scholar
  10. World HealthOrganization (WHO). WHO Informal Consultation on Fever Management in Peripheral Health Care Settings: A Global Review of evidence and Practice. WHO. 2013; http://www.who.int/malaria/publications/atoz/9789241506489/en/.
  11. Archibald LK, Reller LB. Clinical microbiology in developing countries. Emerg Infect Dis. 2001;7(2):302–5.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Gwer S, Newton CRJC, Berkley JA. Over-diagnosis and Co-morbidity of severe malaria in African children: a guide for clinicians. Am J Trop Med Hyg. 2007;77(SUPPL. 6):6–13.PubMedPubMed CentralGoogle Scholar
  13. O’Meara WP, Mott JA, Laktabai J, Wamburu K, Fields B, Armstrong J, et al. Etiology of pediatric fever in western Kenya: a case-control study of falciparum malaria, respiratory viruses, and streptococcal pharyngitis. Am J Trop Med Hyg. 2015;92:1030–7.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Crump JA, Ramadhani HO, Morrissey AB, Saganda W, Mwako MS, Yang LY, et al. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania. Clin Infect Dis. 2011;52(3):341–8.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Crump JA, Ramadhani HO, Morrissey AB, Msuya LJ, Yang LY, Chow SC, et al. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern Tanzania. Trop Med Int Heal. 2011;16(7):830–7.View ArticleGoogle Scholar
  16. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis. 2006;42(3):377–82.View ArticlePubMedGoogle Scholar
  17. Were T, Davenport GC, Hittner JB, Ouma C, Vulule JM, Ong'echa JM, et al. Bacteremia in Kenyan children presenting with malaria. J Clin Microbiol. 2011;49(2):671–6.View ArticlePubMedPubMed CentralGoogle Scholar
  18. World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. In: Guidelines for the management of common illnesses; 2013. p. 125–43.Google Scholar
  19. Schweich PJ, Smith KM, Dowd MD, Walkley EI. Pediatric emergency medicine practice patterns: a comparison of pediatric and general emergency physicians. Pediatr Emerg Care. 1998;14(2):89–94.View ArticlePubMedGoogle Scholar
  20. Crump JA, Morrissey AB, Nicholson WL, Massung RF, Stoddard RA, Galloway RL, et al. Etiology of severe non-malaria febrile illness in northern Tanzania: a prospective cohort study. PLoS Negl Trop Dis. 2013;7(7):e2324.View ArticlePubMedPubMed CentralGoogle Scholar
  21. D’Acremont V, Kilowoko M, Kyungu E, Philipina S, Sangu W, Kahama-Maro J, et al. Beyond malaria — causes of fever in outpatient Tanzanian children. N Engl J Med. 2014;370(9):809–17.View ArticlePubMedGoogle Scholar
  22. Mahende C, Ngasala B, Lusingu J, Butichi A, Lushino P, Lemnge M, et al. Aetiology of acute febrile episodes in children attending Korogwe District hospital in North-Eastern Tanzania. PLoS One. 2014;9(8):e104197.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Elfving K, Shakely D, Andersson M, Ali AS, Baltzell K, Xu WP, et al. Acute uncomplicated febrile illness in children aged 2-59 months in zanzibar-assessment of infectious disease etiologies and infections requiring antibiotics. Am J Trop Med Hyg. 2014;91(5):315.Google Scholar
  24. Kiemde F, Spijker R, Mens PF, Tinto H, Boele M, Schallig HDFH. Aetiologies of non-malaria febrile episodes in children under 5 years in sub-Saharan Africa. Trop Med Int Heal. 2016;21(8):943–55.View ArticleGoogle Scholar
  25. INSD et ICF International. Enquête Démographique et de Sante´ et a` Indicateurs Multiples du Burkina Faso 2010. in French: Institut National de la Statistique et de la Démographie (INSD) et ICF International; 2012.Google Scholar
  26. District Sanitaire de Nanoro. Plan Strategique 2016 du District Sanitaire de Nanoro. 2016;Google Scholar
  27. Berezin EN, Iazzetti MA. Evaluation of the incidence of occult bacteremia among children with fever of unknown origin. Braz J Infect Dis. 2006;10(6):396–9.View ArticlePubMedGoogle Scholar
  28. Msaki BP, Mshana SE, Hokororo A, Mazigo HD, Morona D. Prevalence and Predictors of urinary tract infection and severe malaria among febrile children attending Makongoro health Centre in Mwanza city, north-western Tanzania. Arch Public Health. 2012;70(1):4.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Nitiema LW, Nordgren J, Ouermi D, Dianou D, Traore AS, Svensson L, et al. Burden of rotavirus and other enteropathogens among children with diarrhea in Burkina Faso. Int J Infect Dis. 2011;15:e646–52.View ArticlePubMedGoogle Scholar
  30. Martin NG, Sadarangani M, Pollard AJ, Goldacre MJ. Hospital admission rates for meningitis and caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. Lancet Infect Dis. 2014;14(5):397–405.View ArticlePubMedGoogle Scholar
  31. Ruizendaal E, Dierickx S, Peeters Grietens K, Schallig HDFH, Pagnoni F, Mens PF. Success or failure of critical steps in community case management of malaria with rapid diagnostic tests: a systematic review. Malar J. 2014;13:229.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352(1):39–47.View ArticlePubMedGoogle Scholar
  33. Lundgren IS, Heltshe SL, Smith AL, Chibwana J, Fried MW, Duffy PE. Bacteremia and malaria in Tanzanian children hospitalized for acute febrile illness. J Trop Pediatr. 2015;61(2):81–5.View ArticlePubMedGoogle Scholar
  34. Walsh AL, Phiri AJ, Graham SM, Molyneux EM, Molyneux ME. Bacteremia in febrile Malawian children: clinical and microbiologic features. Pediatr Infect Dis J. 2000;19(4):312–8.View ArticlePubMedGoogle Scholar
  35. Ibeneme CA, Oguonu T, Okafor HU, Ikefuna AN, Ozumba UC. Urinary tract infection in febrile under five children in Enugu, south eastern Nigeria. Niger J Clin Pract. 2014;17:624–8.View ArticlePubMedGoogle Scholar
  36. Bonkoungou IJ, Haukka K, Osterblad M, Hakanen AJ, Traore AS, Barro N, et al. Bacterial and viral etiology of childhood diarrhea in Ouagadougou, Burkina Faso. BMC Pediatr. 2013;13:36.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Simpore J, Ouermi D, Ilboudo D, Kabre A, Zeba B, Pietra V, et al. Aetiology of acute gastro-enteritis in children at saint camille medical Centre, Ouagadougou, Burkina Faso. Pakistan J Biol Sci. 2009;12(3):258–63.View ArticleGoogle Scholar
  38. Thriemer K, Ley B, Ame S, von Seidlein L, de Pak G, Chang NY, et al. The burden of invasive bacterial infections in Pemba, Zanzibar. PLoS One. 2012;7(2):e30350.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Christopher A, Mshana SE, Kidenya BR, Hokororo A, Morona D. Bacteremia and resistant gram-negative pathogens among under-fives in Tanzania. Ital J Pediatr. 2013;39:27.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Mtove G, Amos B, von Seidlein L, Hendriksen I, Mwambuli A, Kimera J, et al. Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies. PLoS One. 2010;5:e9244.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Maltha J, Guiraud I, Kabore B, Lompo P, Ley B, Bottieau E, et al. Frequency of severe malaria and invasive bacterial infections among children admitted to a rural hospital in Burkina Faso. PLoS ONE [Electronic Resour]. 2014;9(2):e89103.View ArticleGoogle Scholar
  42. Okunola PO, Ibadin MO, Ofovwe GE, Ukoh G. Co-existence of urinary tract infection and malaria among children under five years old: a report from Benin City. Nigeria Saudi J Kidney Dis Transpl. 2012;23(3):629–34.PubMedGoogle Scholar
  43. Musa-Aisien AS, Ibadin OM, Ukoh G, Akpede GO. Prevalence and antimicrobial sensitivity pattern in urinary tract infection in febrile under-5s at a children’s emergency unit in Nigeria. Ann Trop Paediatr. 2003;23:39–45.View ArticlePubMedGoogle Scholar
  44. Rabasa AI, Gofama MM. Urinary tract infection in febrile children in Maiduguri north eastern Nigeria. Niger J Clin Pract. 2009;12:124–7.PubMedGoogle Scholar
  45. Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, et al. Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14(1):189.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Ouedraogo Yugbare SO, Ouedraogo R, Nenebi A, Traore B, Congo L, Yonli F, et al. Infections a virus respiratoire syncytial (VRS) au CHU pediatrique Charles de Gaulle de Ouagadougou, Burkina Faso. Bull la Société Pathol Exot. 2016;109(1):20–5.View ArticleGoogle Scholar
  47. Kwofie TB, Anane YA, Nkrumah B, Annan A, Nguah SB, Owusu M. Respiratory viruses in children hospitalized for acute lower respiratory tract infection in Ghana. Virol J. 2012;9:78.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Kabra SK, Lodha R, Broor S, Chaudhary R, Ghosh M, Maitreyi RS. Etiology of acute lower respiratory tract infection. Indian J Pediatr. 2003;70(1):33–6.View ArticlePubMedGoogle Scholar
  49. Akinbo FO, Omoregie R, Mordi R, Okaka CE. Prevalence of malaria and Anemia among young children in a tertiary Hospital in Benin City, Edo state, Nigeria. Fooyin J Heal Sci. 2009;1(2):81–4.View ArticleGoogle Scholar
  50. Ewusie JE, Ahiadeke C, Beyene J, Hamid JS. Prevalence of anemia among under-5 children in the Ghanaian population: estimates from the Ghana demographic and health survey. BMC Public Health. 2014;14:626.View ArticlePubMedPubMed CentralGoogle Scholar
  51. McKenzie FE, Prudhomme WA, Magill AJ, Forney JR, Permpanich B, Lucas C, et al. White blood cell counts and malaria. J Infect Dis. 2005;192(2):323–30.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

Advertisement